Consultant, LDMH Partners
Dr Nishat Hyder-Rahman is a consultant at LDMH Partners and postdoctoral researcher at the Faculty of Law and Criminology, Vrije Universiteit Brussel, Belgium.
A couple from British Columbia, Canada, have been embroiled in a complex ethical battle after their surrogate refused their request to abort the fetus she was carrying. The couple made the request after tests revealed the baby would likely be born with Down's syndrome...
The California Institute for Regenerative Medicine (CIRM) in San Francisco has approved a further $243 million to encourage researchers working on stem cell therapies to push forward into the clinical trial phase...
The US Food and Drug Administration (FDA) has demanded a federal injunction from the US District Court of the District of Columbia to stop Regenerative Sciences (a Colorado based stem cell clinic) from using patients' own stem cells as medicinal treatment...
Proposals to genetically test incoming freshman and transfer students to the University of California, Berkeley (UCB), are under fire. UCB intended to offer a genetic test to its thousands of entrants, which would test three variants: genes that affect the ability to absorb folic acid, metabolise alcohol and digest lactose....
According to the most extensive public survey yet the British public are at ease with the idea of synthetic biology - but only if it is responsibly regulated....
The Vatican announced on Friday it is to finance research into the potential use of adult stem cells for therapeutic purposes. It has agreed to donate two million Euros to a research project led by the University of Maryland's School of Medicine in the US to investigate the use of intestinal adult stem cells for treating disease...
Over a year since US President Barack Obama announced his decision to allow federal funding for embryonic stem cell research, the widely utilised cell lines, H9 and H7, are still weeks away from receiving federal funding approval. The H9 and H7 cell lines were derived and approved under the Bush administration and are currently owned by WiCell Research Institute in Madison, Wisconsin. However, for months now the fate of these two much used lines has been uncertain. According to...
The Australian federal five-year moratorium on the use of gender selection technology in IVF (in vitro fertilisation) treatment for so-called 'social' reasons ends this year, reopening this controversial debate. The Australian health watchdog, the National Health and Medical Research Council (NHMRC), confirmed that that it will be conducting a review of this issue, beginning within the next few months, after the completion of its ongoing review of the Research Involving Human E...
The US National Institutes of Health (NIH) has approved the first human embryonic stem cell (ES) line from the George W Bush era, according to Nature News. It will be included on the National Stem Cell Registry (NSCR), ensuring its eligibility for federal funding....
The pioneering genetics research company, deCODE, reemerged last week as a private company with new financial backing. Based in Reykjavik, Iceland, the original company deCODE Genetics, Inc led the way internationally in genetic testing and diagnostics for over a decade. With unique access to genetic information from Iceland's isolated population, the biotech firm has made important discoveries, such as identifying gene variants associated with common conditions ...
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.
